Hydrason Injection

Hydrocortisone Sodium Succinate

Composition : Hydrason IV/IM Injection : Each vial contains sterile powder of Hydrocortisone 100 mg as Hydrocortisone Sodium Succinate USP.

Indication : Hydrocortisone sterile powder is indicated for IV or IM use in the following conditions : Primary or secondary adrenocortical insufficiency, Acute adrenocortical insufficiency, Shock unresponsive to conventional therapy, Congenital adrenal hyperplasia, Hypercalcemia associated with cancer, Nonsuppurative thyroiditis, Rheumatic Disorders, Dermatologic Diseases (Allergic States, Severe seborrheic dermatitis, Severe psoriasis, Pemphigus, Severe erythema multiforme). Control of severe or incapacitating allergic conditions (Bronchial asthma, Contact dermatitis, Atopic dermatitis, Serum sickness, Seasonal or perennial allergic rhinitis, Drug hypersensitivity reactions, Urticarial transfusion reactions, Acute non infections laryngeal edema), Ophthalmic Diseases (Herpes zoster opthalmicus, Iritis, Iridocyclitis, Chorioretinitis, Diffuse posterior uveitis and choroiditis, Optic neuritis), Gastrointestinal Diseases, Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, Loeffler's syndrome, Aspiration pneumonitis, Hematologic Disorders (Acquired, autoimmune hemolytic anaemia, Idiopathic thrombocytopenic purpura in adults, Secondary thrombocytopenia, Erythroblastopenia), Neoplastic Diseases (Leukemias and lymphomas in adults, Acute leukemia of childhood). Edematous States, Acute exacerbations of multiple sclerosis

Dosage and administration : By IM injection or slow IV injection or infusion. The initial dose of Hydrocortisone sterile powder in 100 mg to 500 mg, depending on the severity of the condition. This dose may be repeated at intervals of 2, 4 or 6 hours as indicated by the patient's response and clinical condition. Children : By slow IV Injection, up to 1 year 25 mg, 1-5 years 50 mg, 6 -12 years 100mg. Or, as directed by the registered physician.

Use in pregnancy and lactation : There are no adequate and well-controlled studies in pregnant women. It should be used durign pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk. Caution should be exercised when this medicine is administered to a nursing woman.

Packing : Hydrason IV/IM Injection : Each Combipack contains 1 vial of Hydrocortisone 100 mg (as Hydrocortisone Sodium Succinate USP sterile powder) with 1 ampoule of 2 ml water for injection BP.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2020 Designed and Developed by ATI Limited.